Madelon Maurice (principal investigator at CMM), Laigo Bio and collaborators receive EIC Pathfinder grant for novel precision strategy in cancer treatment.

Read more about this exciting work here.

Previous
Previous

On February 10th, Lars Kemp (Gloerich lab) successfully defended his thesis entitled: ‘Out of touch: Signaling by cell adhesions in diffuse-type gastric cancer’. Congratulations Dr. Kemp! 

Next
Next

Cassio Fleming and Jurian Schuijers publish their review on the potential of therapeutic targeting of biomolecular condensates in disease treatments.